ARCHIVES

Yarbro Refuses To Seek Core Renewal, Quits Director Post

This article is from The Cancer Letter archive.

Vol. 04 No. 38 | September 22, 1978

Download PDF Visit The Full Archive

Related Articles

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981